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Edited by Judit Ova´diAbstract In human (h) pyruvate dehydrogenase complex
(PDC) the pyruvate dehydrogenase (E1) is bound to the E1-bind-
ing domain of dihydrolipoamide acetyltransferase (E2). The
C-terminal surface of the E1b subunit was scanned for the
negatively charged residues involved in binding with E2. bD289
of hE1 interacts with K276 of hE2 in a manner similar to the
corresponding interaction in Bacillus stearothermophilus PDC.
In contrast to bacterial E1b, the C-terminal residue of the
hE1b does not participate in the binding with positively charged
residues of hE2. This latter ﬁnding shows species speciﬁcity in
the interaction between hE1b and hE2 in PDC.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The pyruvate dehydrogenase complex (PDC) plays a central
role in glucose metabolism by linking glycolysis and the tricar-
boxylic acid cycle. PDC catalyzes the oxidative decarboxyl-
ation of pyruvic acid with formation of carbon dioxide,
acetyl-CoA, NADH, and H+ through the action of the three
catalytic components: (i) pyruvate dehydrogenase (E1) catalyz-
ing the decarboxylation of pyruvate and reductive acetylation
of the lipoyl moieties of dihydrolipoamide acetyltransferase
(E2); (ii) E2 transferring acetyl moiety to CoA; and (iii) dihy-
drolipoamide dehydrogenase (E3) reoxidizing the reduced lip-
oyl moieties of E2 with the reduction of NAD+ to NADH
[1,2].
The structure of PDC is based on two types of symmetry:
icosahedral in eukaryotes and some Gram-positive bacteria
and octahedral in Gram-negative bacteria determined by theAbbreviations: PDC, pyruvate dehydrogenase complex; E1, pyruvate
dehydrogenase; E2, dihydrolipoamide acetyltransferase; E3, dihydro-
lipoamide dehydrogenase; BP, E3-binding protein; L2S, fragment
containing the second lipoyl domain (L2), the second hinge region, the
E1-binding domain and the third hinge region of human E2; DCPIP,
2,6-dichlorophenolindophenol; SPR, surface plasmon resonance
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domains connected by ﬂexible hinge regions: (i) 1–3 lipoyl
domains (two for human PDC, the outer domain, named L1,
and the inner domain, named L2); (ii) E1/E3-binding (or sub-
unit-binding) domain of E2 interacting with E1 in eukaryotes
and with both E1 and E3 in bacteria; and (iii) inner domain,
forming the central core of PDC and carrying the catalytic
reaction of E2 [1,2]. Lipoyl groups are covalently attached to
speciﬁc lysine residues of the lipoyl domains forming a ‘‘swing-
ing arm’’. The lipoyl domains visit the active sites of E1, E2,
and E3 coupling the individual PDC reactions and carrying
acetyl moieties and reducing equivalents. Higher eukaryotes
have an additional structural component, i.e. E3-binding pro-
tein (BP) with domain structure similar to E2 [3]. Human E2
(hE2) and hBP form the central core of hPDC to which all
other components are bound. In mammalian PDC 20–30 het-
erotetramers of E1 (a2b2) are bound to the E1-binding domain
of E2 and 6–12 homodimers of E3 are bound to the E3-binding
domain of BP [4].
E1s of icosahedral PDCs having tetrameric structure (a2b2)
bind to their cognate E2s through the C-terminals of their b
subunits [5].The structure of the subcomplex of Bacillus stearo-
thermophilus E1 (bsE1) with the E1/E3-binding domain of E2
was determined [5]. In branched-chain a-keto acid dehydroge-
nase complex its ﬁrst catalytic component (branched-chain a-
keto acid dehydrogenase) with a2b2 structure is also suggested
to bind to its cognate E2 through its b subunits close to the
twofold axis [6]. E1s of octahedral PDCs which are homodi-
mers bind to E2 through the N-terminal region as was found
for Escherichia coli and Azotobacter vinelandii E1s [7,8]. Here,
we identify the speciﬁc amino acids involved in the binding of
hE1 to the E1-binding domain of hE2.2. Materials and methods
2.1. Protein expression and puriﬁcation
Site-directed mutagenesis was performed using Quick-change site-di-
rected mutagenesis kit (Stratagene). The complete coding sequences of
all constructs were veriﬁed by DNA sequencing. Recombinant hE1
and hE1 mutants were overexpressed in E. coli BL21 and puriﬁed using
Ni–nitrilotriacetate–agarose chromatography as reported previously
[9,10]. Recombinant hE2-BP and hE3 were overexpressed in E. coli
and puriﬁed [9]. Recombinant hL2S [containing the second lipoyl do-
main (L2), second hinge region, E1-binding domain (S) and third hinge
region of hE2; residues 128–330] and L2S mutants were overexpressed
in E. coli BL21 and puriﬁed by Ni–nitrilotriacetate–agarose aﬃnity
chromatography [10]. The enzyme preparations had purities of 90–
96% determined by densitometry of SDS–polyacrylamide gels (results
not shown).ation of European Biochemical Societies.
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Activities of wild-type and mutant hE1s were determined by two as-
says: (i) PDC assays, by the formation of NADH during the overall
PDC reaction after reconstitution of hE1s with hE2-BP and hE3 into
PDC and (ii) by 2,6-dichlorophenolindophenol (DCPIP) assays, by the
reduction of DCPIP, an artiﬁcial electron acceptor, to measure the ﬁrst
partial reaction of E1s, the decarboxylation of pyruvate in the absence
of the second substrate, lipoyl moieties of hE2 as described previously
[9]. One unit of enzyme activity is deﬁned as 1 lmol of product formed
per min per mg of protein at 37 C.
The wild-type and mutant hE1s and hL2S and its mutants were sub-
jected to gel-ﬁltration chromatography on Superdex HP200 to detect
binding of hE1 to the E1-binding domain of hE2. E1 (200 lg) and
L2S were incubated at varying ratios at room temperature for
30 min in 300 ll of 50 mM potassium phosphate buﬀer, pH 7.5 with
150 mM NaCl (both proteins were stable under these conditions) be-
fore applying to a Superdex HP200 column. The elution peaks corre-
sponding to the subcomplex of two proteins and free L2S were
collected and analyzed by calculating the peak areas and identiﬁcation
of proteins by SDS–polyacrylamide gel electrophoresis.
2.3. Surface plasmon resonance (SPR)
SPR measurements were performed on a BIAcore X instrument.
hL2S was immobilized on a CM5 chip through the lipoyl moiety by
a surface thiol coupling method [10]. hE1 at 0–500 nM was injected
to interact with the sensor surface [10]. Duplicate runs were performed
for each concentration. The reference cell on the surface of which hL2S
was not immobilized was used to subtract non-speciﬁc binding. Exper-
imental data were analyzed with BIAevaluation software to calculate
the association and dissociation rate constants and the equilibrium dis-
sociation constant.3. Results and discussion
Prior to the structure of bsE1 bound to the E1/E3-binding
domain of bsE2 was reported, the negatively charged residues
and the C-terminal residues of the b subunits of bsE1 were sug-
gested to participate in its binding to bsE2 [11]. Based on this
information we screened the surface of the b subunit of hE1 for
the possible candidates for electrostatic interactions and pre-
pared eight mutants eliminating negatively charged residues:
bE229A, bE229Q, bE232A, bE232Q, bE234A, bE234Q,
bD289A, and bD289N (Fig. 1). Additionally we created two
mutants with the C-terminal residue either replaced or deleted,
i.e. bI329A and bI329del.E229
E232
E234
I329
N328
N257 D289
F285
F285
F287
L288
Fig. 1. The C-terminal domains of hE1b subunits. E1bs are colored green and
The residues investigated are colored in red. The possible candidates for ele
interactions with hE2 are in violet.E1 catalyzes two successive steps: (i) the decarboxylation of
pyruvate to CO2 to form the intermediate 2-a-hydroxyethylid-
ene-thiamin pyrophosphate and (ii) the reductive acetylation
of the lipoyl groups attached to E2. Fig. 2 shows the compar-
ison of the activities of hE1 mutants measured in two assays:
DCPIP assays to determine the eﬀect of each mutation on
the ﬁrst partial reaction, i.e. decarboxylation of pyruvate;
and PDC assays to determine the eﬀect of each mutation on
the complete E1 reaction (two partial reactions). The ﬁrst par-
tial reaction does not require E1 to be bound to E2, while the
complete E1 reaction measured by PDC assays involves inter-
action of E1 with E2. Mutant hE1s: bE229A, bE229Q,
bE232A, bE232Q, bE234A, and bE234Q did not show drastic
changes compared to the wild-type E1 activities in PDC and
DCPIP assays. Activities of these mutants ranged from 67%
to 106% in PDC assay and from 43% to 84% in DCPIP assay.
The activities of hE1-bD289A and hE1-bD289N in the DCPIP
assay did not change indicating that interactions of mutant
hE1s with thiamin pyrophosphate and pyruvate were not af-
fected. However, the hE1-bD289A mutant did not have any
detectable activity in PDC assays and the activity of hE1-
bD289N was reduced by 36%, suggesting that substitution
with alanine prevented binding to hE2 while substitution with
asparagine reduced the eﬃciency of interaction with hE2 but
did not eliminate it completely probably by formation of a
hydrogen bond instead of the salt bridge. bI329A and bI329del
at the C-terminal of hE1 showed similar reductions (37–43%
for bI329A and 57–62% for bI329del) in activity in both the
DCPIP and PDC assays, suggesting that mutation of bI329
possibly resulted in destabilization of the protein interaction
because of a local conformation change rather than by aﬀect-
ing the hE1 binding to hE2 directly.
Interaction of the wild-type and mutant hE1s with the di-do-
main (L2S) was investigated using Superdex HP200 gel-ﬁltra-
tion analysis. Fig. 3 shows a typical elution proﬁle of hE1
plus the L2S of hE2 at molar ratio of 1:1. The formation of
a subcomplex was clearly detected (retention time 42 min).
The corresponding peak of hE1-L2S subcomplex eluted before
hE1 (retention time 47 min) and hL2S (retention time 52 min).
By resolving the eluted protein subcomplexes formed at
diﬀerent molar ratios on SDS–PAGE the stoichiometry wasE229
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N257N328D289
F287
L288
blue. Only residues investigated and discussed in the text are displayed.
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Fig. 2. Activities of the wild-type and mutant hE1s. Activities were measured in the PDC assay (black bars) by the formation of NADH
after reconstitution of hE1 with hE2-BP and hE3 in PDC and by the DCPIP assay (grey bars) by the reduction of DCPIP. Results are means ± S.E.
(n = 4–6). Wild-type 100% activity for E1 in PDC was 28 U/mg protein and in DCPIP-assay was 160 mU/mg protein.
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Fig. 3. Subcomplex formation between hE1-D289A and hL2S. Elution proﬁles of the hE1-WT and E1-D289A from Superdex HP200. (d) E1-WT
(1.3 nmol); (j) E1-WT (1.3 nmol) and hL2S (1.3 nmol) at the 1:1 molar ratio; (m) E1-D289A (1.3 nmol) and hL2S (1.3 nmol) at the 1:1 molar ratio;
and (,) L2S (1.3 nmol).
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of hL2S. The same stoichiometry of binding was observed for
bsPDC proteins [5,12]. The gel-ﬁltration analysis of the hE1-
bD289A interaction with hL2S revealed that a subcomplex
was not formed. This ﬁnding is consistent with zero activity
in PDC assay (Fig. 2).
Binding of hE1 mutants to the E1-binding domain of hE2
was directly analyzed by the SPR. hL2S was bound through
the lipoyl group to the surface of the chip making it possible
for the E1-binding domain of hE2 to interact with hE1. Table 1
shows the binding parameters for the wild-type and mutanthE1s. The hE1 mutants can be divided into three groups sim-
ilar to the results of activity data. The mutations of residues
bE229, bE232, and bE234 did not result in the large changes
in the binding aﬃnity of hE1 to hL2S. The highest fold in-
crease in KD is seen for bE234Q in this group, equal to only
2.9-fold. In contrast, bD289A did not show any detectable
binding by SPR and the KD for bD289N binding was about
119-fold higher compared to the wild-type hE1. Two mutants
of the C-terminal of hE1 displayed only modest increases in
KD (2.5-fold for bI329A and 5.4-fold for bI329del). These
changes indicate that the substitution of bI329 changes the
Table 1
Binding parameters for the wild-type and mutant hE1s interaction with
the wild-type and mutant hL2Ss
E1 L2S ka (mM
1 s1) kd (s
1) KD (nM) Fold
WT WT 1300 0.0123 9.47 1.0
E229A WT 2205 0.0115 5.52 0.6
E229Q WT 859 0.0119 13.82 1.5
E232A WT 686 0.0121 17.8 1.9
E232Q WT 1006 0.0120 11.85 1.3
E234A WT 826 0.0122 14.70 1.6
E234Q WT 601 0.0168 27.85 2.9
D289A WT UD UD UD
D289N WT 7.71 0.0097 1128 119
I329A WT 822 0.0193 23.45 2.5
I329del WT 486 0.0246 50.70 5.4
E3-WT WT UD UD UD
WT K276A 190.5 0.1545 810.5 86
WT R297A 656 0.0417 64.1 6.8
Binding parameters were determined by SPR as described in Section 2.
UD, undetectable.
Italicised area shows the absence of binding between the wild-type hE3
and the wild-type hL2S.
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bI329 is involved in the direct interaction with the E1-binding
domain of hE2. As expected hE3 was not able to bind to hL2S
(Table 1).
The recently determined structure of the subcomplex of bsE1
with the E1/E3-binding domain of bsE2 [5] provides some in-
sight into binding of hE1 to the E1-binding domain of hE2.
In bacteria both E1 and E3 bind to the E1/E3-binding domain
of cognate E2. Comparison of the two B. stearothermophilus
structures of bsE1 bound to the E1/E3-binding domain of
bsE2 and bsE3 bound to the same domain of bsE2 revealed3.10
3.17
R1
K137
hI329 hD289
bE285
bF324
Fig. 4. Superimposition of the structures of hE1b and B. stearothemophilus (b
blue; bsE1, green; the E1/E3-binding domain of bsE2, yellow (with its resi
Performed using InsightII/Discover software.that several residues of the E1/E3-binding domain of bsE2
are involved in the interactions with both bsE1 and bsE3.
However, the diﬀerences in thermodynamic parameters
showed that formation of the subcomplex of bsE3 with the
E1/E3-binding domain of bsE2 is driven by the entropy change
while a higher enthalpy change is found during the formation
of the subcomplex of bsE1 with the E1/E3-binding domain of
bsE2. bsE1 is bound by several electrostatic interactions, espe-
cially (residues of bsE1 and the E1-binding domain of bsE2,
respectively): bE285 and E2-R136, b 0F324 and E2-R157,
bF324 and E2-K137; hydrophobic interactions between E2-
M132 and E2-P133; the hydrophobic pocket of E1 formed
by residues 281-2-86 from both b subunits; and additional
hydrogen bonds including water molecules [5].
The superimposition of the hE1 and bsE1 structures (Fig. 4)
revealed that hE1-bD289 occupies the same position as bsE1-
bE285 and could be involved in a salt bridge with K276 of hE2
(corresponding to R136 of bsE2). This hypothesis was tested
further by creating mutant K276A of hL2S. The SPR revealed
that K276A had negligible binding with 86-fold higher KD
compared to wild-type hL2S (Table 1). The superimposition
of the two E1 structures also uncovered that the C-terminal
residues (I329) of hE1bs are located too far from either hE2-
K277 (another lysine in hL2S, corresponding to K137 in
bsE2) or hE2-R297 (corresponding to R157 in bsE2) to form
salt bridges. The mutant R297A of hL2S was found to have
KD 6.8-fold higher than that for the wild-type hL2S (Table
1), indicating a possible involvement of this residue in the
interaction; however, not with the C-terminal residue of
hE1b subunit. Possible candidates for the interactions with
K277 and R297 of hE2 are two residues of hE1 (bN257 and
bN328) located on the surface of b subunits close to the
position of the C-terminal residues of bsE1. Residues2.96 3.04
R157
36
hI329
hD289
bE285 bF324
s) E1b with E1/E3-binding domain of bsE2. Proteins are colored: hE1,
dues in red). Residues of interest are displayed with the side chains.
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and may participate in hydrophobic interaction with hE2.
In summary, binding of hE1 involves electrostatic interac-
tions (one of which is between hE1-bD289 and hE2-K276).
The C-terminal residue of hE1b is probably not involved in
the binding to hE2, and this is diﬀerent from that reported
for bsE1. Our ﬁndings may explain the monospeciﬁcity in
the interaction between hE1 and L2S of hE2 which diﬀers from
that observed for bsE1 and bsE3 binding to the subunit-bind-
ing domain of bsE2.
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